Management of desmoids and other benign soft tissue tumours (2024 – CME) – online course
Description
Authors: J. Garnon and J. Jennings
Reviewers: A. Barnacle, A. Kovács, A. Najafi, C. Nice and P.M. Paprottka
This course corresponds to chapter 2.2.4.2 Percutaneous ablation of bone and soft tissue lesions of the European Curriculum and Syllabus for IR.
Abstract
Desmoid tumours and other benign soft tissue tumours (notably vascular malformations) are rare tumours that are difficult to treat. Systemic treatments and local therapies (surgery, radiation therapy) are associated with a certain morbidity which is hardly acceptable in patients who are otherwise young and healthy in most of the cases. Moreover, the efficacy of those treatments is somehow limited in many situations. Interventional radiology has emerged as a valuable alternative to treat these tumours. The experience was initially based on case reports, but several retrospective studies have now demonstrated the efficacy and safety of percutaneous interventions. Contraindications to treatments are rare and can be overcome in most case using optimal image guidance, appropriate ablation modality and use of ancillary protective techniques. Results mostly depend upon patient and tumour selection. Although the complete response rate may be limited, percutaneous procedures are effective in achieving tumour control and symptom palliation.
Learning objectives
- To learn the pathophysiology of desmoid tumours and other benign soft tissue tumours
- To learn which patient is the ideal candidate for interventional radiology
- To learn how to choose and perform ablation
- To learn how to choose and perform protective measures
- To learn how to manage the patient post-operatively
- To learn which follow-up should be scheduled
- To learn about the expected outcomes
- To learn about the treatment-related complications
Further information
This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for IR and corresponds to chapter 2.2.4.2 Percutaneous ablation of bone and soft tissue lesions.
The format of the course is interactive and easy to use, including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour and is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 1.5 European CME credits (ECMEC). The CME accreditation for this course will expire on January 29, 2026. A non-CME accredited version of the course will remain available for two more years.
The acquired CME Certificate will be available in the myCIRSE area under CIRSE Academy.
The enrolment period of this course is linked to the validity of the All-Access Pass.
Release date: January 2024
